Leukemia—Health Professional Version
There are different types of leukemia, including acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, and hairy cell leukemia. Find evidence-based information on leukemia treatment, research, genomics, and statistics.
Adult Leukemia Treatment
-
Acute Lymphoblastic Leukemia Treatment (PDQ®)
Get detailed information about the molecular genetics, prognosis, and treatment of ALL in this summary for clinicians.
-
Acute Myeloid Leukemia Treatment (PDQ®)
Get detailed information on acute myeloid (myelogenous) leukemia (AML) treatment, including treatment options and cytogenetic analysis to help predict treatment outcomes, in this summary for clinicians.
-
Chronic Lymphocytic Leukemia Treatment (PDQ®)
Get detailed information about newly diagnosed and recurrent CLL and available treatment modalities in this summary for clinicians.
-
Chronic Myeloid Leukemia Treatment (PDQ®)
Get detailed information on chronic myeloid leukemia (CML) treatment, including tyrosine kinase inhibitors and high-dose therapy with allogeneic transplant, in this summary for clinicians.
-
Hairy Cell Leukemia Treatment (PDQ®)
Get detailed information on hairy cell leukemia treatment, including surveillance, chemotherapy, targeted therapy, immunotherapy, and splenectomy, in this clinician summary.
Childhood Leukemia Treatment
-
Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)
Get information about risk factors, signs, diagnosis, molecular features, survival, risk-based treatment assignment, and induction and postinduction therapy for children and adolescents with newly diagnosed and recurrent ALL.
-
Childhood Acute Myeloid Leukemia Treatment (PDQ®)
Get detailed information on childhood acute myeloid leukemia (AML) treatment, including chemotherapy, stem cell transplant, and targeted therapy, in this clinician summary.
-
Childhood Myeloid Proliferations Associated With Down Syndrome Treatment (PDQ®)
Get detailed information on treatment for myeloid proliferations associated with Down syndrome, including chemotherapy and stem cell transplant, in this clinician summary.
-
Childhood Myelodysplastic Neoplasms Treatment (PDQ®)
Get detailed information on childhood myelodysplastic neoplasm treatment, including stem cell transplant, other therapies, and supportive care, in this clinician summary.
-
Juvenile Myelomonocytic Leukemia Treatment (PDQ®)
Get detailed information on juvenile myelomonocytic leukemia (JMML) treatment, including stem cell transplant and supportive care, in this clinician summary.
-
Childhood Chronic Myeloid Leukemia Treatment (PDQ®)
Get detailed information on childhood chronic myeloid leukemia treatment, including tyrosine kinase inhibitor therapy, stem cell transplant, and supportive care, in this clinician summary.
-
Childhood APL Treatment (PDQ®)
Get detailed information on childhood acute promyelocytic leukemia (APL) treatment, including tretinoin, arsenic trioxide, chemotherapy, and other therapies, in this clinician summary.
-
Pediatric HSCT and Cellular Therapy for Cancer (PDQ®)
Get detailed information about autologous and allogeneic transplant, HLA matching, preparative regimens, and complications in this summary for clinicians.
Additional Leukemia Information and Resources
-
Drugs Approved for Leukemia
This page lists cancer drugs approved by the FDA for use in leukemia. The list includes generic names, brand names, and common drug combinations, which are shown in capital letters.
-
Treatment Clinical Trials for Leukemia
Find a list of leukemia treatment clinical trials and use the filters to refine the results.
-
Advances in Leukemia Research
Clinical advances, research findings, and NCI programs that are leading to progress in treating leukemia.
-
Leukemia Statistics
Leukemia statistics based on data from large groups of patients to be used as a general guide.
Genetics
-
RUNX1-Familial Platelet Disorder
Learn about the clinical features and management of RUNX1-familial platelet disorder (RUNX1-FPD), a hereditary hematologic malignancy syndrome associated with the RUNX1 gene.
-
DDX41-Associated Myeloid Malignancies
Learn about the clinical features and management of DDX41-associated myeloid malignancies, a hereditary hematologic malignancy syndrome associated with the DDX41 gene.
-
CEBPA-Associated Familial Acute Myeloid Leukemia
Learn about the clinical features and management of CEBPA-associated familial AML, a hereditary hematologic malignancy syndrome associated with the CEBPA gene.
-
GATA2 Deficiency Syndrome
Learn about the clinical features and management of GATA2 deficiency syndrome, a hereditary hematologic malignancy syndrome associated with the GATA2 gene.
-
Genetics of Hereditary Hematologic Malignancies
Get detailed information about hereditary hematologic malignancies in this clinician summary.
-
MBD4-Associated Neoplasia Syndrome
Learn about the clinical features and management of MBD4-associated neoplasia syndrome, a hereditary cancer syndrome associated with the MBD4 gene.